Wulf Palinski

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Seppo Ylä‐Herttuala, Wulf Palinski, Michael E. Rosenfeld et al. · Journal of Clinical Investigation · 1989 · 1.9K citations · Full text

Vascular Disease, Pathology, Hyperlipidemia +19

Low density lipoprotein undergoes oxidative modification in vivo.

Wulf Palinski, Michael E. Rosenfeld, Seppo Ylä‐Herttuala et al. · Proceedings of the National Academy of Sciences · 1989 · 1.5K citations · Full text

Inflammation, Metabolic Syndrome, Low Density Lipoprotein +14

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

J T Salonen, H Korpela, R. Salonen et al. · The Lancet · 1992 · 1.3K citations · Full text

Metabolic Syndrome, Thrombosis, Vascular Disease +10

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.

Claudio Napoli, Francesco Paolo D’Armiento, Francesco Paolo Mancini et al. · Journal of Clinical Investigation · 1997 · 986 citations · Full text

Hyperlipidemia, Oxidative Stress, Metabolic Syndrome +16

Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

Andrew C. Li, Kathleen K. Brown, Mercedes Silvestre et al. · Journal of Clinical Investigation · 2000 · 840 citations · Full text